Schedule 13G ownership disclosure
Invivyd Inc
Common Stock · CUSIP: 00534A102
Event date: 2025-09-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- JANUS HENDERSON GROUP PLC
Shares: 25,383,077 · Class: 12.1%
- Janus Henderson Biotech Innovation Master Fund Ltd
Shares: 21,576,145 · Class: 10.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001274173-25-000285
- Form type
- SCHEDULE 13G/A
- Filer
- Invivyd, Inc.
- CIK
- CIK 1832038
- Filed
- Nov 14, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership